Enlivex Therapeutics Ltd.

NASDAQ:ENLV

Biotechnology

Healthcare
$4.26 +2.67%

+$0.19 today

Market cap
$71.70M
Beta
1.52
P/E (TTM)
0.0
EPS (TTM)
$407.81
52W Low $6.42High $31.50

Volume 0.06M

Average 0.44M

Income Statement

Follow revenue through to earnings.

Revenue

$0.00

FY 2025 · Annual

Operating Income

-$15.00M

FY 2025 · Annual

Net Income

$1.24B

FY 2025 · Annual

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue00000
Cost of Revenue546K777K835K545K332K
Gross Profit(546K)(777K)(835K)(545K)(332K)
Gross Margin—————
Research & Development12.88M18.69M19.24M10.13M8.92M
Selling, General & Admin6.24M6.7M6.14M4.91M5.69M
Operating Expenses19.29M25.8M29.4M14.99M14.67M
Depreciation & Amortization546K777K835K545K332K
EBITDA(18.74M)(25.02M)(28.22M)(14.47M)(14.67M)
EBITDA Margin—————
Operating Income(19.29M)(25.8M)(29.4M)(15.54M)(15M)
Operating Margin—————
Interest Income120K835K1.57M1.07M792K
Interest Expense328K5.26M14K13K13K
Other Income / Expenses4.82M(5.26M)327K522K1.63B
Income Before Tax(14.47M)(31.06M)(29.07M)(15.01M)1.62B
Pre-Tax Margin—————
Income Tax Expense0000382.65M
Net Income(14.47M)(31.06M)(29.07M)(15.01M)1.24B
Net Margin—————
EPS (Basic)(8.10)(34.65)(23.40)(10.95)405.60
EPS (Diluted)(8.10)(34.65)(23.40)(10.95)382.20
Weighted Avg Shares1.19M1.23M1.24M1.37M3.05M
Weighted Avg Shares (Diluted)1.19M1.23M1.24M1.37M3.23M

ENLV Earnings Waterfall · TTM

NASDAQ:ENLV · Revenue to Net Income

Key Ratios

EPS$381.90
Gross Margin0.0%
Net Margin0.0%
P/E Ratio-2.0
P/S Ratio0.0

Analysis

$0 of revenue converted into $1.2B of net income for the selected period. Gross margin is 0.0% and net margin is 0.0%, showing how much revenue survives after costs and taxes. EPS is $381.90, tying the income statement back to per-share earnings.

Competitors

Peer companies in the same sector

Health

Recent Filings

Recent regulatory filings

FilingDescriptionDate
6-K6-K filingJul 20, 2026
6-K6-K filingJul 13, 2026
6-K6-K filingJul 7, 2026
6-K6-K filingJun 24, 2026
6-K6-K filingJun 22, 2026

How much revenue does ENLV generate?

Enlivex Therapeutics Ltd. (ENLV) reported $0.00 of revenue in fiscal 2025.

Is ENLV profitable?

Enlivex Therapeutics Ltd. (ENLV) reported $1.24B of net income.